Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
Dear colleagues,
 
The Belgian Early Warning System Drugs at the Scientific Institute of Public Health (WIV-ISP) was informed on the analysis of a tablet containing the new psychoactive substance: pCPP (para-chlorophenylpiperazine), a synthetic piperazine derivative.
This substance was not been detected in Belgium so far.
The tablet was submitted through the Modus Fiesta drug testing project in Brussels; assuming to be ecstasy but containing pCPP and amphetamine base.
The tablet characteristics can be found in the table below:
 
Logo:
No logo
Shape
round
Lenght:
8 mm
Width:
/
Thickness:
5 mm
Weight:
230 mg
Colour:
pink
Substance:
amphetamine + pCPP
 
 
 
A number of piperazine derivatives has been reported as recreational drugs. The isomers, predominantly mCPP, have been used as surreptitious substitutes for MDMA and have also been found as contaminant in amphetamine products.
Scientific research has demonstrated pCPP to have serotonergic effects, likely acting as a non-selective serotonin receptor agonist and/or releasing agent.
Possible adverse effects are headaches, nausea, severe hallucinations.
All relevant data including spectra can be found in the fact sheet in attachment.
 
 
In addition, the BEWSD has again been informed of the analysis of several ecstasy tablets containing a high amount of MDMA.
All tablets were recently analysed in the framework of the Modus Fiesta drug testing service in Brussels; the tablets’ characteristics can be found in the table below:
 
Logo:
Transformer
xtc
? star ?
Rolls Royce
TML
Minion
Skull with star
Shape
mask
rectangular
schield
rectangular
logo
logo
logo
Lenght:
7 mm
5 mm
7 mm
12 mm
12 mm
12 mm
11 mm
Width:
5 mm
3 mm
8 mm
6 mm
11 mm
8 mm
9 mm
Thickness:
9 mm
 /
3 mm
4 mm
4 mm
5 mm
Weight:
360 mg
480 mg
410 mg
330 mg
410 mg
290 mg
310 mg
Colour:
purple
purple
grey-pink
yellow-green
Purple
yellow
blue
Substance:
MDMA
MDMA
MDMA
MDMA
MDMA
MDMA
MDMA
MDMA base content:
~150.5 mg
~192.96 mg
~223.3 mg
181.4 mg
179.7 mg
155.6 mg
162 mg
Picture :
 
 
 
 
 
 
 
 
The BEWSD would like to draw your attention to these tablets, and would like to remind you that the majority of ecstasy tablets currently circulating are highly dosed. The amount of MDMA present in an ecstasy tablet can only be determined using laboratory analysis!
Earlier this year, the BEWSD already warned for a similar ‘skull with star’-tablet, though containing other characteristics (different weight and amount of MDMA base).
 
Symptoms of an MDMA overdose are characterised by heavy sweating, tremor, dry mouth, nausea, vomiting, elevated blood pressure and heart rate, paranoia and hyperthermia.
In severe cases a serotonin syndrome can occur, resulting in an often fatal hyperthermia.
 
Please inform your networks, and don’t hesitate to contact us if you receive signals about similar tablets.
 
Kind regards,
 
Belgian Early Warning System on Drugs
 
 
 
 
DISCLAIMER
The information in this message is exclusively meant for the EWS-network, and was sent to you, as a member of this network, in a confidential way.
Therefore the information in this message may not be copied, transferred or made public without the prior permission of the WIV-ISP.
The WIV-ISP takes responsibility for the editing of a press release, if considered as necessary in the framework of its mission.
The information contained in this document is also available on the BEWSD-website (with corresponding pdf-files and analytical data).
This part of the website is not accessible for the general public. A login can be requested by contacting ews.drugs@wiv-isp.be.
 
BEWSD ALERT LEVELS
The BEWSD has decided to distinguish its alert messages depending on the severity of the reported information. The following 4 alert levels are used, and will always be indicated between brackets ([]) in the subject line of the alert message.